4132 Share Price Performance
NT$3.47
-10.98 (-75.99%)
Price NT$3.47
Share Pricen/a
Golden Biotechnology Corporation Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
4132 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
No trending discussion available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Golden Biotechnology Corporation Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -1.94
- -25.10%
- -706.41%
- 148.4%
About 4132
- Founded
- 2002
- Employees
- n/a
- CEO
- WebsiteView website
Golden Biotechnology Corporation engages in research and development of new drug in Taiwan. The company offers Antroquinonol for the treatment of pancreatic cancer, acute myeloid leukemia, blood diseases, non-small cell lung cancer, COVID-19, and other diseases. It is also involved in development and sale of health foods and supplements, as well as provides products for oncology, infectious, and neurodegenerative diseases. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.
